Medtronic Investor Presentation November 2022

Medtronic's November 2022 investor handout details the company's strategic transformation toward accelerated growth, including a new operating model, portfolio optimization through planned business separations, and a robust product pipeline with 180 approvals in the prior 12 months. The presentation emphasizes near-term catalysts in fast-growing medtech markets, ESG commitments toward carbon neutrality by FY30, and shareholder value creation through capital allocation and dividend policies.